HealthEquity Crecimiento futuro

Future controles de criterios 4/6

Se prevé un crecimiento anual de los beneficios y los ingresos de HealthEquity de 41.1% y 12.6% por año respectivamente. Se prevé que el BPA crezca en un 46.1% al año. Se espera que la rentabilidad financiera sea de 15.1% en 3 años.

Información clave

41.4%

Tasa de crecimiento de los beneficios

46.5%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	17.3%
Tasa de crecimiento de los ingresos	12.6%
Rentabilidad financiera futura	15.1%
Cobertura de analistas	Good
Última actualización	18 May 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

HealthEquity, Inc.'s (NASDAQ:HQY) Intrinsic Value Is Potentially 51% Above Its Share Price

Oct 26

Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

Jul 27

HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jul 07

Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

Apr 18

Estimating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

Mar 14

Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

Dec 24

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Dec 02

Is HealthEquity, Inc. (NASDAQ:HQY) Expensive For A Reason? A Look At Its Intrinsic Value

Nov 11

These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

Sep 08

HealthEquity Non-GAAP EPS of $0.33 in-line, revenue of $206.1M beats by $2.22M

Sep 06

HealthEquity: Asymmetry In Valuation Continues To Widen

Aug 25

HealthEquity COO steps down, CEO to assume his responsibilities

Aug 02

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Jul 27

Calculating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

Jul 06

These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

May 24

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Apr 12

An Intrinsic Calculation For HealthEquity, Inc. (NASDAQ:HQY) Suggests It's 29% Undervalued

Mar 16

HealthEquity: Quality Firm, But Not Likely Worth The Price

Mar 01

These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

Jan 28

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Jan 02

HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 26% Below Their Intrinsic Value Estimate

Dec 09

Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

Oct 10

Is There An Opportunity With HealthEquity, Inc.'s (NASDAQ:HQY) 36% Undervaluation?

Sep 05

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Aug 09

Previsiones de crecimiento de beneficios e ingresos

NasdaqGS:HQY - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
1/31/2027	1,462	211	446	490	4
1/31/2026	1,315	160	382	419	12
1/31/2025	1,155	85	262	291	13
1/31/2024	1,000	56	197	243	N/A
10/31/2023	971	29	176	221	N/A
7/31/2023	938	13	169	212	N/A
4/30/2023	901	-8	121	175	N/A
1/31/2023	862	-26	32	151	N/A
10/31/2022	831	-59	21	146	N/A
7/31/2022	795	-62	-71	120	N/A
4/30/2022	778	-55	-76	117	N/A
1/31/2022	757	-44	4	141	N/A
10/31/2021	741	-6	10	151	N/A
7/31/2021	741	1	99	181	N/A
4/30/2021	728	4	108	198	N/A
1/31/2021	734	9	85	182	N/A
10/31/2020	747	3	64	152	N/A
7/31/2020	724	-20	34	117	N/A
4/30/2020	635	0	35	95	N/A
1/31/2020	532	40	63	105	N/A
10/31/2019	407	53	72	107	N/A
7/31/2019	320	90	96	118	N/A
4/30/2019	304	93	96	116	N/A
1/31/2019	287	74	98	113	N/A
10/31/2018	272	67	82	101	N/A
7/31/2018	258	61	67	95	N/A
4/30/2018	244	56	56	89	N/A
1/31/2018	230	47	48	82	N/A
10/31/2017	216	46	N/A	76	N/A
7/31/2017	202	41	N/A	70	N/A
4/30/2017	190	32	N/A	59	N/A
1/31/2017	178	26	N/A	46	N/A
10/31/2016	167	25	N/A	39	N/A
7/31/2016	155	24	N/A	35	N/A
4/30/2016	141	20	N/A	27	N/A
1/31/2016	127	17	N/A	27	N/A
10/31/2015	116	15	N/A	23	N/A
7/31/2015	107	14	N/A	17	N/A
4/30/2015	97	13	N/A	15	N/A
1/31/2015	88	12	N/A	15	N/A
10/31/2014	80	1	N/A	16	N/A
7/31/2014	74	-1	N/A	16	N/A
4/30/2014	68	-4	N/A	16	N/A
1/31/2014	62	-7	N/A	18	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (41.1% al año) de HQY es superior a la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Se prevé que los beneficios (41.1% al año) de HQY crezcan más rápidamente que el mercado US (14.7% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de HQY crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (12.6% al año) de HQY crezcan más rápidamente que los del mercado US (8.1% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 12.6% al año) de HQY crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de HQY sea baja dentro de 3 años (15.1%).

HealthEquity Crecimiento futuro

Future controles de criterios 4/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Consensus EPS estimates increase by 19%

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ended January 31, 2024 and Fiscal Year Ending January 31, 2025

Consensus EPS estimates increase by 39%

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2024 and 2025

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2024

HealthEquity, Inc. Provides Earnings Guidance for the Year Ending January 31, 2024

Recent updates

HealthEquity, Inc. to Report Q1, 2025 Results on Jun 03, 2024

Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?

HealthEquity, Inc., Annual General Meeting, Jun 27, 2024

Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues

President notifies of intention to sell stock

HealthEquity: Multiple Compression Has Finally Made It A Buy

Full year 2024 earnings: EPS exceeds analyst expectations

HealthEquity, Inc. to Report Q4, 2024 Results on Mar 19, 2024

Consensus EPS estimates increase by 19%

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ended January 31, 2024 and Fiscal Year Ending January 31, 2025

Investors Appear Satisfied With HealthEquity, Inc.'s (NASDAQ:HQY) Prospects

Consensus EPS estimates increase by 39%

Founder & Vice Chairman notifies of intention to sell stock

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2024 and 2025

Is HealthEquity (NASDAQ:HQY) A Risky Investment?

HealthEquity, Inc. to Report Q3, 2024 Results on Dec 05, 2023

HealthEquity, Inc.'s (NASDAQ:HQY) Intrinsic Value Is Potentially 51% Above Its Share Price

President notifies of intention to sell stock

HealthEquity, Inc. (NasdaqGS:HQY) entered into a definitive agreement to acquire BenefitWallet’s Health Savings Account (HSA) portfolio from Conduent Business Services, LLC for $425 million.

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2024

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

HealthEquity, Inc. to Report Q2, 2024 Results on Sep 05, 2023

HealthEquity, Inc. Announces the Termination of the Employment of Larry Trittschuh, Executive Vice President and Chief Security Officer

Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 37% Below Their Intrinsic Value Estimate

President notifies of intention to sell stock

Executive VP & CTO recently sold US$653k worth of stock

HealthEquity, Inc. Announces Change of CFO

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

HealthEquity, Inc. Provides Earnings Guidance for the Year Ending January 31, 2024

HealthEquity, Inc. to Report Q1, 2024 Results on Jun 05, 2023

Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

Full year 2023 earnings: EPS exceeds analyst expectations

Estimating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

Independent Director recently sold US$325k worth of stock

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023 and January 31, 2024

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

HealthEquity, Inc. to Report Q3, 2023 Results on Dec 06, 2022

Is HealthEquity, Inc. (NASDAQ:HQY) Expensive For A Reason? A Look At Its Intrinsic Value

Executive VP notifies of intention to sell stock

Executive VP & Chief Security Officer exercised options and sold US$67k worth of stock

Independent Director recently sold US$300k worth of stock

Independent Director recently sold US$1.8m worth of stock

These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023

HealthEquity Non-GAAP EPS of $0.33 in-line, revenue of $206.1M beats by $2.22M

Healthequity, Inc. Elects Paul M. Black to Board of Directors and to Audit and Risk Committee and Talent, Compensation and Culture Committee

HealthEquity: Asymmetry In Valuation Continues To Widen

HealthEquity, Inc. to Report Q2, 2023 Results on Sep 06, 2022

HealthEquity, Inc. Announces Executive Changes

HealthEquity COO steps down, CEO to assume his responsibilities

Now 21% undervalued after recent price drop

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Now 21% undervalued after recent price drop

Calculating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

Consensus forecasts updated

Executive VP & COO notifies of intention to sell stock

First quarter 2023 earnings: EPS exceeds analyst expectations

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023

These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

HealthEquity, Inc. to Report Q1, 2023 Results on Jun 06, 2022

HealthEquity, Inc., Annual General Meeting, Jun 23, 2022

HealthEquity, Inc. Expands Board of Directors

Insufficient new directors

Price target increased to US$76.62